DM, B., PK, K., M, M., G, S., JS, H., RY, K., . . . Schneider, S. (2006). Ranibizumab versus verteporfin for neovascular age-related macular degeneration. New England Journal of Medicine, 355(14), 1432.
Chicago Style (17th ed.) CitationDM, Brown, et al. "Ranibizumab Versus Verteporfin for Neovascular Age-related Macular Degeneration." New England Journal of Medicine 355, no. 14 (2006): 1432.
MLA (9th ed.) CitationDM, Brown, et al. "Ranibizumab Versus Verteporfin for Neovascular Age-related Macular Degeneration." New England Journal of Medicine, vol. 355, no. 14, 2006, p. 1432.
Warning: These citations may not always be 100% accurate.
